The Board denied the veteran's claims for service connection for a skin disorder due to exposure to Agent Orange and on a direct basis, finding that his skin disorders were not related to service or Agent Orange exposure.
The deciding factor: The VA examiner found no evidence of a nexus between the veteran's current skin disorders and his in-service exposure to Agent Orange.
- Claimed conditions
- seborrheic dermatitis, possible tinea pedis
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- June 20, 2003
- Citation
- 0313488
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0313488.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board remands the claims for service connection for alopecia areata or alopecia androgenic, pseudofolliculitis barbae, and seborrheic dermatitis due to a need for additional evidence.
- Partly granted
The Board granted a 10 percent disability rating for dermatitis, variously diagnosed as seborrheic dermatitis, dermatophytosis, and tinea versicolor, prior to June 5, 2023, but denied a higher rating from that date. The issues related to Raynaud's syndrome and special monthly compensation were remanded.
- Remanded (sent back)
The Board remands the matter for further development to ensure compliance with previous remand instructions, specifically regarding obtaining a medical opinion from an appropriate specialist and notifying the Veteran about the unavailability of his separation examination.
- Partly granted
The Board granted an initial 30 percent rating for migraine headaches prior to December 5, 2016, and a 50 percent rating from May 31, 2024. The claims for increased ratings for Raynaud's syndrome and seborrheic dermatitis were denied.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.